Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita.
about
The genetics of dyskeratosis congenitaCap-Independent Translational Control of CarcinogenesisCould the eIF2α-Independent Translation Be the Achilles Heel of Cancer?Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human diseaseGuarding the 'translation apparatus': defective ribosome biogenesis and the p53 signaling pathwayDiverse diseases from a ubiquitous process: the ribosomopathy paradoxNF-κB1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterningThe complete chemical structure of Saccharomyces cerevisiae rRNA: partial pseudouridylation of U2345 in 25S rRNA by snoRNA snR9Specialized ribosomes: a new frontier in gene regulation and organismal biology.New frontiers in translational control of the cancer genomeAcute dyskerin depletion triggers cellular senescence and renders osteosarcoma cells resistant to genotoxic stress-induced apoptosis.Dysregulating IRES-dependent translation contributes to overexpression of oncogenic Aurora A Kinase.Andrographolide induces apoptosis of C6 glioma cells via the ERK-p53-caspase 7-PARP pathway.The cancerous translation apparatusp53 Isoforms: An Intracellular Microprocessor?Marrow failure: a window into ribosome biologyRibosomopathies: mechanisms of disease.Cellular differences in protein synthesis regulate tissue homeostasis.Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorderA novel Bcr-Abl-mTOR-eIF4A axis regulates IRES-mediated translation of LEF-1Cellular IRES-mediated translation: the war of ITAFs in pathophysiological states.Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells.Dual mechanisms of translation initiation of the full-length HIV-1 mRNA contribute to gag synthesis.Animal models of Diamond Blackfan anemia.Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing.RNA regulons in Hox 5' UTRs confer ribosome specificity to gene regulation.Inactivation of X-linked tumor suppressor genes in human cancer.rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells.Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.In Vivo Senescence in the Sbds-Deficient Murine Pancreas: Cell-Type Specific Consequences of Translation Insufficiency.Differential Requirements for eIF4E Dose in Normal Development and CancerAKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.Dyskeratosis congenita and the DNA damage response.Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.Deregulation of Internal Ribosome Entry Site-Mediated p53 Translation in Cancer Cells with Defective p53 Response to DNA Damage.Translational control in cancer etiology.H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation.eIF2α phosphorylation bypasses premature senescence caused by oxidative stress and pro-oxidant antitumor therapies.A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment.
P2860
Q24599906-D0DEAF7C-0DD9-4A17-9CA8-93A34ADD2DAEQ26744030-CAD324CD-C278-4DA9-B9CA-EA58A52BE6ADQ26774488-E339FED4-569F-466B-9612-E866C6248B7FQ27016076-6C597B52-EE4B-44EE-842B-E1AFB6370778Q27022918-E0FBBF7D-4282-4A0D-BD54-9222AB520F9BQ27694538-866CD21B-037A-40C4-BAFA-660C2016B04BQ28393889-DAF423C1-0D32-4D1C-A0D2-1C48AB00A594Q28591034-372D60BE-A42B-41F8-A554-B672C90D3A2AQ28822098-ABCA5442-9ED5-43D9-A6AB-0E98C9A04724Q33689623-EF19A943-6683-40D8-8F61-6E5CFC05032CQ33853235-8D0BB361-C5F0-420E-97A9-BE59123D5521Q33897629-F7363B07-D76F-4170-9D38-71218ABBEF91Q33944846-E5800ADB-7CCE-48D1-B703-5254735BAA32Q34069873-49972C35-64C0-4D37-8A79-CD7555446665Q34182649-3AE108EF-262C-402D-9B1C-6D9C259C1489Q34202703-EEDCEFCE-B4A0-4DF6-88E9-1A5E49A2654AQ34431422-8755F466-8009-4035-8E03-9E7C19C44A18Q34454066-739CEBFD-45D6-42FE-9F30-89F3F5AE9F3CQ34462292-AED691BE-1CA0-443E-9E0F-177D210CE427Q34474968-E4D04655-0A8C-4649-972D-54E0ECC643CAQ34589167-F130AF5D-3B19-4775-B3A6-3609E0C145F5Q34624747-276BB7B9-16D3-42E4-81AF-E74615BB2E03Q34707415-EF71C335-690C-433B-A01A-BF868EA1DEF5Q34826811-ABE14739-6546-4F76-8088-783FF9053CB8Q35017968-82465D9D-F0B4-4BEA-9096-A896D2CB2C22Q35053490-5A801026-E150-4756-8178-D1FC0F693720Q35159261-59645F49-D486-4427-977B-602847F5639DQ35206452-CC5A3992-1862-4921-B67F-BFD0537AAC55Q35569577-6B0D1EE8-BCB2-441F-B608-A4750BBF2AC0Q35620795-4D9A2E54-6DA1-4D75-8A31-BEC1DE811916Q35658181-BBA62854-D762-4FC3-A5D4-A0E4540B4D1CQ35816049-F32ADBAC-55A2-417D-BDF5-46EC5F72AAC5Q35886886-845315E8-CF4F-4C42-ABB3-753AB2824038Q35895247-604B9784-B5A2-4392-BC6D-26EE6A911CC2Q36083918-DD197475-4B80-4FBB-B223-72E3764588F2Q36234278-8399BBCF-9430-45E0-AB5D-0C65D6ADFA54Q36555212-F4188D3B-3577-417A-BAB0-078B7F6BC725Q37378023-BD61ED85-BDC8-4BB3-9187-F14EE764F0ECQ37445048-68E87FA5-500B-4B0A-9E57-F1B45D3FCC24Q37482750-11D5B825-C690-4158-8562-E20A37004F7F
P2860
Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Deregulation of oncogene-induc ...... linked dyskeratosis congenita.
@ast
Deregulation of oncogene-induc ...... linked dyskeratosis congenita.
@en
type
label
Deregulation of oncogene-induc ...... linked dyskeratosis congenita.
@ast
Deregulation of oncogene-induc ...... linked dyskeratosis congenita.
@en
prefLabel
Deregulation of oncogene-induc ...... linked dyskeratosis congenita.
@ast
Deregulation of oncogene-induc ...... linked dyskeratosis congenita.
@en
P2093
P2860
P356
P1433
P1476
Deregulation of oncogene-induc ...... linked dyskeratosis congenita.
@en
P2093
Cristian Bellodi
Davide Ruggero
Noam Kopmar
P2860
P304
P356
10.1038/EMBOJ.2010.83
P407
P577
2010-05-07T00:00:00Z